Axcella granted patent for long COVID fatigue treatment

Axcella granted patent for long COVID fatigue treatment

Submitted by admin on August 30, 2023 - 11:21pm
Source: 
Medical Marketing and Media
News Tags: 
Axcella Therapeutics
COVID-19
Long COVID
AXA1125
patents
Headline: 
Axcella granted patent for long COVID fatigue treatment
snippet: 


Axcella Therapeutics said this week that it has moved to tighten up patent protection for lead asset AXA1125, an experimental treatment for long COVID fatigue.

Do Not Allow Advertisers to Use My Personal information